![Pei Jian Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pei Jian Wang
Director Financiero/CFO en XinYu Pharmaceutical Co., Ltd. .
Cargos activos de Pei Jian Wang
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Director Financiero/CFO | 01/05/2019 | - |
Contacto de Relaciones con Inversores | - | - | |
Secretario Corporativo | 01/05/2019 | - |
Historial de carrera de Pei Jian Wang
Estadísticas
Internacional
China | 2 |
Operativa
Director of Finance/CFO | 1 |
Investor Relations Contact | 1 |
Corporate Secretary | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
XinYu Pharmaceutical Co., Ltd.
![]() XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
- Bolsa de valores
- Insiders
- Pei Jian Wang
- Experiencia